Overall rank by patents
#26,413
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).
The verdict
Grasslanz holds 10 US patents across 11 technology areas, rank #26,413 of 50,000 tracked assignees.
Grasslanz Technology Limited has been granted 10 US utility patents between 2015 and 2024, placing Grasslanz Technology Limited at rank #26,413 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a Foreign Corporation, Grasslanz Technology Limited is one of the more focused assignees in the PatentsView dataset. By volume, Grasslanz sits between Goodman Global Group, Inc. (10 patents, rank #26,409) and Grifols Therapeutics Inc. (10 patents, rank #26,417) - the closest US assignees by grant volume. The composite Innovation Score of 43.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 8 in the 2015–2019 window, a -75% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Grasslanz Technology Limited's 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Grasslanz Technology Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Goodman Global Group, Inc.
10 patents
Gouda-Torgerson Building Systems LLC
10 patents
Grand General Accessories Manufacturing
10 patents
Grand Valley State University
10 patents
Green Bay Packaging, Inc.
10 patents
GreenOnyx LTD
10 patents
Greyfin LLC
10 patents
Grifols Therapeutics Inc.
10 patents
Grasslanz Technology Limited
10 patents
What this shows Grasslanz holds 10 patents at rank #26,413, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Grasslanz's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 20.0% |
| 2016 | 3 | 30.0% |
| 2017 | 1 | 10.0% |
| 2018 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2023 | 1 | 10.0% |
| 2024 | 1 | 10.0% |
Top 11 of 11 technology areas
Overall rank by patents
#26,413
Across all tracked assignees
43.1 out of 100
How to use this portfolio
Grasslanz's 10 grants land it in the top 29% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.